JAMIE BOSNJAK: Open Payments
NPI 1538942446 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 119 payments from 13 companies in 2025. Trend: 2023 $130 · 2024 $1,444 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $329 |
| Lundbeck LLC | 20 | $227 |
| Supernus Pharmaceuticals, Inc. | 18 | $224 |
| Janssen Pharmaceuticals, Inc | 11 | $191 |
| Teva Pharmaceuticals USA, Inc. | 9 | $169 |
| Corium, LLC | 5 | $145 |
| Neurocrine BioSciences, Inc. | 6 | $126 |
| Alkermes, Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
Products named: REXULTI, Qelbree, INVEGA SUSTENNA, ABILIFY MAINTENA, Azstarys, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
